Literature DB >> 7884562

Soybean phytoestrogen intake and cancer risk.

C H Adlercreutz1, B R Goldin, S L Gorbach, K A Höckerstedt, S Watanabe, E K Hämäläinen, M H Markkanen, T H Mäkelä, K T Wähälä, T Adlercreutz.   

Abstract

Because many Western diseases are hormone-dependent cancers, we have postulated that the Western diet, compared with a vegetarian or semi-vegetarian diet, may alter hormone production, metabolism or action at the cellular level. Recently, our interest has been focused on the cancer-protective role of some hormone-like diphenolic phytoestrogens of dietary origin, the lignans and isoflavonoids. The precursors of the biologically active compounds originate in soybean products (mainly isoflavonoids but also lignans), as well as whole grain cereals, seeds, probably berries and nuts (mainly lignans). The plant lignan and isoflavonoid glycosides are converted by intestinal bacteria to hormone-like compounds with weak estrogenic and antioxidative activity; they have now been shown to influence not only sex hormone metabolism and biological activity but also intracellular enzymes, protein synthesis, growth factor action, malignant cell proliferation, differentiation and angiogenesis, making them strong candidates for a role as natural cancer protective compounds. Epidemiological investigations support this hypothesis, because the highest levels of these compounds are found in countries or regions with low cancer incidence. This report is a review of results that suggest that the diphenolic isoflavonoids and lignans are natural cancer-protective compounds.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884562     DOI: 10.1093/jn/125.3_Suppl.757S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  68 in total

1.  Complementary medicine for prostate cancer: effects of soy and fat consumption.

Authors:  M A Moyad; W A Sakr; D Hirano; G J Miller
Journal:  Rev Urol       Date:  2001

2.  Effects of fermented soy milk on the liver lipids under oxidative stress.

Authors:  Ching-Yi Lin; Zheng-Yu Tsai; I-Chi Cheng; Shyh-Hsiang Lin
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells.

Authors:  Rui Zhao; Nong Xiang; Fredrick E Domann; Weixiong Zhong
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

4.  Eating habits and pancreas cancer.

Authors:  S Ohba; M Nishi; H Miyake
Journal:  Int J Pancreatol       Date:  1996-08

Review 5.  Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment.

Authors:  Melanie J Grubisha; Donald B DeFranco
Journal:  Steroids       Date:  2013-02-01       Impact factor: 2.668

6.  Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner.

Authors:  Yilan Li; Jennifer S Ross-Viola; Neil F Shay; David D Moore; Marie-Louise Ricketts
Journal:  J Nutr       Date:  2009-03-18       Impact factor: 4.798

7.  Effect of genistein on cholesterol metabolism-related genes in a colon cancer cell line.

Authors:  Maria Notarnicola; Caterina Messa; Antonella Orlando; Benedetta D'Attoma; Valeria Tutino; Rosemary Rivizzigno; Maria Gabriella Caruso
Journal:  Genes Nutr       Date:  2008-04       Impact factor: 5.523

8.  Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.

Authors:  Yiwei Li; Mingxin Che; Sunita Bhagat; Kerrie-Lynn Ellis; Omer Kucuk; Daniel R Doerge; Judith Abrams; Michael L Cher; Fazlul H Sarkar
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

9.  Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats.

Authors:  Hongwei Si; Dongmin Liu
Journal:  J Nutr       Date:  2008-02       Impact factor: 4.798

10.  Supplementary health benefits of soy aglycons of isoflavone by improvement of serum biochemical attributes, enhancement of liver antioxidative capacities and protection of vaginal epithelium of ovariectomized rats.

Authors:  Tu-Fa Lien; Yu-Lin Hsu; Dan-Yuan Lo; Robin Yy Chiou
Journal:  Nutr Metab (Lond)       Date:  2009-04-09       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.